Filing Flows › InfuSystem Holdings (INFU) › Q2 2026 › vs Q2 2025
InfuSystem Holdings (INFU) Q2 2026 vs Q2 2025 (year over year)
InfuSystem Holdings's revenue rose $931K (+3%) from $36.0M in Q2 2025 to $36.9M in Q2 2026. Gross margin 58.0% against 55.2% (+2.8 pts).
InfuSystem Holdings, Q2 2026: revenue $36.9M (+3% year over year), operating margin 11.2%, net earnings $3.2M, operating cash flow $6.8M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 58.0% | 55.2% | +2.8 pts |
| Operating margin | 11.2% | 10.5% | +0.8 pts |
| Net margin | 8.7% | 7.2% | +1.5 pts |
| Free cash flow margin | 18.1% | 18.9% | -0.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $36.9M | $36.0M | $931K | +3% |
| Gross profit | $21.4M | $19.9M | $1.5M | +8% |
| Cost of revenue | $15.5M | $16.1M | −$608K | -4% |
| Operating profit | $4.2M | $3.8M | $375K | +10% |
| Operating expenses | $17.3M | $16.1M | $1.2M | +7% |
| Pre-tax earnings | $3.9M | $3.4M | $425K | +12% |
| Other expense, net | $281K | $331K | −$50K | -15% |
| Sales & marketing | $3.0M | $2.7M | $285K | +11% |
| General & admin | $14.1M | $13.1M | $951K | +7% |
| Other operating costs | $175K | $247K | −$72K | -29% |
| Net earnings | $3.2M | $2.6M | $632K | +24% |
| Income tax | $640K | $847K | −$207K | -24% |
| Depreciation & amortization | $3.2M | $3.3M | −$166K | -5% |
| Share-based compensation | $1.2M | $661K | $581K | +88% |
| Working capital & other | $871K | −$408K | $1.3M | — |
| Operating cash flow | $6.8M | $7.0M | −$232K | -3% |
| Free cash flow (OCF − capex) | $6.7M | $6.8M | −$106K | -2% |
| Capital expenditures | $91K | $217K | −$126K | -58% |
Questions
How much did InfuSystem Holdings's revenue grow year over year in Q2 2026?
InfuSystem Holdings's revenue rose $931K (+3%) from $36.0M in Q2 2025 to $36.9M in Q2 2026. Gross margin 58.0% against 55.2% (+2.8 pts).